US Patent 11098368 ALK and NTRK1 fusion molecules and uses thereof
Patent 11098368 was granted and assigned to Foundation Medicine on August, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11098368 ALK and NTRK1 fusion molecules and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.